METHOD OF TREATING PATIENTS WITH NOVEL CORONAVIRUS INFECTION COVID-19 WITH SPONTANEOUS RESPIRATION Russian patent published in 2024 - IPC A61M16/10 

FIELD: medicine.

SUBSTANCE: invention relates to pulmonology, resuscitation and intensive care, infectious diseases, and can be used to treat patients with pneumonia, caused by novel coronavirus infection COVID-19 of moderate and severe severity. Nitrogen oxide is inhaled through the patient’s open mouth during spontaneous breathing from distance of 9 cm with nitrogen oxide concentration of 1,200 ppm for 5 minutes 2 times a day. Additionally, the skin surface of the patient’s anterior chest is treated with nitrogen oxide flows by scanning from distance of 9 cm with concentration of 1,200 ppm for 5 minutes 2 times a day. Procedures are carried out for 5–10 days until relief of signs of respiratory failure.

EFFECT: method enables reducing the risk of the patient’s lethal outcome due to the inhalation therapy with nitrogen oxide, which enables to prevent the development of a cytokine storm, eliminate endothelial dysfunction and acute respiratory distress syndrome, restore capillary function and protect oxygen-sensitive organs.

1 cl, 3 dwg, 3 ex